Modeling Plasma Virus Concentration during Primary HIV Infection

BONHOEFFER, 1997, Virus dynamics and drug therapy, Proc. Nat. Acad. Sci. U.S.A., 94, 6971, 10.1073/pnas.94.13.6971 BORROW, 1997, Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus, Nat. Med., 3, 205, 10.1038/nm0297-205 CLARK, 1991, High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection, New Engl. J. Med., 324, 954, 10.1056/NEJM199104043241404 COLLINS, 1998, HIV-1 nef protein protects infected primary cells against killing by cytotoxic T lymphocytes, Nature, 391, 397, 10.1038/34929 DAAR, 1991, Transient high levels of viremia in patients with primary human immunodeficiency virus type 1, New Engl. J. Med., 324, 961, 10.1056/NEJM199104043241405 D'ARGENIO, 1997 DEBOER, 1998, Target cell limited and immune control models of HIV infection: a comparison, J. theor. Biol., 190, 201, 10.1006/jtbi.1997.0548 ESSUNGER, 1994, Modeling HIV infection of CD4+ T-cell subpopulations, J. theor. Biol., 170, 367, 10.1006/jtbi.1994.1199 GUIDOTTI, 1999, Viral clearance without destruction of infected cells during acute HBV infection, Science, 284, 825, 10.1126/science.284.5415.825 HAASE, 1999, Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues, Ann. Rev. Immunol., 17, 625, 10.1146/annurev.immunol.17.1.625 HO, 1995, Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature, 373, 123, 10.1038/373123a0 HRABA, 1990, Model-based analysis of CD4+ lymphocyte dynamics in HIV infected individuals, Immunobiology, 181, 108, 10.1016/S0171-2985(11)80169-5 JIN, 1999, Dramatic rise in plasma viremia after CD8+ T-cell depletion in SIV-infected macaques, J. Exp. Med., 189, 991, 10.1084/jem.189.6.991 KAHN, 1998, Acute human immunodeficiency virus type 1 infection, New Engl. J. Med., 339, 33, 10.1056/NEJM199807023390107 KAUFMANN, 1998, Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection, J. Infec. Dis., 178, 1812, 10.1086/314480 KIRSCHNER, 1998, Role of the thymus in pediatric HIV-1 infection, J. AIDS Human Retrovirol., 18, 95 KLENERMAN, 1996, Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection, Proc. Nat. Acad. Sci. U.S.A., 93, 15323, 10.1073/pnas.93.26.15323 KOUP, 1994, Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome, J. Virol., 68, 4650, 10.1128/JVI.68.7.4650-4655.1994 LITTLE, 1999, Viral dynamics of acute HIV-1 infection, J. Exp. Med., 190, 141, 10.1084/jem.190.6.841 MACIASZEK, 1997, IL-16 represses HIV-1 promoter activity, J. Immunol., 158, 5, 10.4049/jimmunol.158.1.5 MACKEWICZ, 1995, CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription, Proc. Nat. Acad. Sci. U.S.A., 92, 2231, 10.1073/pnas.92.6.2308 MATANO, 1998, Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques, J. Virol., 72, 164, 10.1128/JVI.72.1.164-169.1998 MCLEAN, 1991, Population dynamics of HIV within an individual after treatment with zidovudine, AIDS, 5, 485, 10.1097/00002030-199105000-00002 MCLEAN, 1990, A model of human immunodeficiency virus infection in T helper cell clones, J. theor. Biol., 147, 177, 10.1016/S0022-5193(05)80051-7 MCLEAN, 1992, Models of interactions between HIV and other pathogens, J. theor. Biol., 155, 69, 10.1016/S0022-5193(05)80549-1 MERRILL, 1989, Modeling the interaction of HIV with cells of the immune response, 83, 371 MITTLER, 1999, Improved estimates for HIV-1 clearance rate and intracellular delay, AIDS, 13, 1415, 10.1097/00002030-199907300-00023 MURRAY, 1998, A model of primary HIV-1 infection, Math. Biosci., 154, 57, 10.1016/S0025-5564(98)10046-9 MUSEY, 1998, Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type I infection, New Engl. J. Med., 337, 1267, 10.1056/NEJM199710303371803 NOWAK, 1990, The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease, AIDS, 4, 1095, 10.1097/00002030-199011000-00007 NOWAK, 1991, Antigenic diversity thresholds and the development of AIDS, Science, 254, 963, 10.1126/science.1683006 NOWAK, 1996, Population dynamics of immune responses to persistent viruses, Science, 272, 74, 10.1126/science.272.5258.74 NOWAK, 1997, Viral dynamics in primary viremia and anti-retroviral therapy in simian immunodeficiency virus infection, J. Virol., 71, 7518, 10.1128/JVI.71.10.7518-7525.1997 NOWAK, 1997, Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations, J. theor. Biol., 184, 203, 10.1006/jtbi.1996.0307 OGG, 1998, Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA, Science, 279, 2103, 10.1126/science.279.5359.2103 PANTALEO, 1997, The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia, Proc. Nat. Acad. Sci. U.S.A., 94, 254, 10.1073/pnas.94.1.254 PERELSON, 1989, Modeling the interaction of the immune system with HIV, 83, 350 PERELSON, 1993, Dynamics of HIV infection of CD4+ T cells, Math. Biosci., 114, 81, 10.1016/0025-5564(93)90043-A PERELSON, 1999, Mathematical analysis of HIV-1 dynamics in vivo, SIAM Rev., 41, 3, 10.1137/S0036144598335107 PERELSON, 1996, HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time, Science, 271, 1582, 10.1126/science.271.5255.1582 PHILLIPS, 1996, Reduction of HIV concentration during acute infection: independence from a specific immune response, Science, 271, 497, 10.1126/science.271.5248.497 RAMRATNAM, 1999, Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis, Lancet, 354, 1782, 10.1016/S0140-6736(99)02035-8 REIBNEGGER, 1989, Stability analysis of simple models for immune cells interacting with normal pathogens and immune system retroviruses, Proc. Nat. Acad. Sci. U.S.A., 86, 2030, 10.1073/pnas.86.6.2026 RINALDO, 1995, High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors, J. Virol., 69, 5838, 10.1128/JVI.69.9.5838-5842.1995 RIVIERE, 1995, Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS, AIDS Res. Human Retroviruses, 11, 903, 10.1089/aid.1995.11.903 SACHSENBERG, 1998, Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 infection as measured by Ki-67 antigen, J. Exp. Med., 187, 1295, 10.1084/jem.187.8.1295 SCHACKER, 1996, Clinical and epidemiologic features of primary HIV infection, Ann. Int. Med., 125, 257, 10.7326/0003-4819-125-4-199608150-00001 SCHENZLE, 1994, A model for AIDS pathogenesis, Statist. Med., 13, 2067, 10.1002/sim.4780131916 SCHMITZ, 1999, Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes, Science, 283, 857, 10.1126/science.283.5403.857 SCHNITTMAN, 1990, Preferential infection of CD4+ memory T cells by human immunodeficiency virus type-1: evidence for a role in the selective T-cell functional defects observed in infected individuals, Proc. Nat. Acad. Sci. U.S.A., 87, 6052, 10.1073/pnas.87.16.6058 STEVENSON, 1990, HIV-1 replication is controlled at the level of T cell activation and proviral integration, EMBO J., 9, 1551, 10.1002/j.1460-2075.1990.tb08274.x STILIANAKIS, 1997, Analysis of a model for the pathogenesis of AIDS, Math. Biosci., 145, 27, 10.1016/S0025-5564(97)00018-7 WALKER, 1986, CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication, Science, 234, 1563, 10.1126/science.2431484 WEI, 1995, Viral dynamics in human immunodeficiency virus type 1 infection, Nature, 373, 117, 10.1038/373117a0 WU, 1999, Characterization of viral dynamics in human immunodeficiency virus type-1 infected patients treated with combination antiretroviral therapy; relationships to host factors, cellular restoration, and virologic end points, J. Infect. Dis., 179, 799, 10.1086/314670 ZACK, 1992, Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle, J. Virol., 66, 1717, 10.1128/JVI.66.3.1717-1725.1992 ZHANG, 1999, Sexual transmission and propagation of SIV and HIV in resting and activated CD4+T cells, Science, 286, 1353, 10.1126/science.286.5443.1353